Inventor · disambiguated record
Glenn Hoke
Also filed as: HOKE GLENN · HOKE GLENN D · HOKE JR GLENN D
15 granted patents·6 pending applications·3,072 citations·filing 1993–2004
96Inventor score
Top patents by PatentIndex Score
21 records- 0199US5587361AOligonucleotides having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Dec 24, 1996·1.4k cites·18 claims
- 0298US5661134AOligonucleotides for modulating Ha-ras or Ki-ras having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Aug 26, 1997·249 cites·18 claims
- 0397US5576302AOligonucleotides for modulating hepatitis C virus having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Nov 19, 1996·255 cites·30 claims
- 0496US5599797AOligonucleotides having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Feb 4, 1997·248 cites·6 claims
- 0595US5585479AAntisense oligonucleotides directed against human ELAM-I RNAUS ARMY·Filed 1993·Granted Dec 17, 1996·328 cites·13 claims
- 0693US5607923AOligonucleotides for modulating cytomegalovirus having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Mar 4, 1997·136 cites·6 claims
- 0789US5635488ACompounds having phosphorodithioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Jun 3, 1997·92 cites·8 claims
- 0889US5506212AOligonucleotides with substantially chirally pure phosphorothioate linkagesISIS PHARMACEUTICALS INC·Filed 1994·Granted Apr 9, 1996·125 cites·6 claims
- 0988US5620963AOligonucleotides for modulating protein kinase C having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Apr 15, 1997·80 cites·6 claims
- 1076US6339066B1Antisense oligonucleotides which have phosphorothioate linkages of high chiral purity and which modulate βI, βII, γ, δ, Ε, ζ and η isoforms of human protein kinase CISIS PHARMACEUTICALS INC·Filed 1997·Granted Jan 15, 2002·29 cites·42 claims
- 1166US5654284AOligonucleotides for modulating RAF kinase having phosphorothioate linkages of high chiral purityISIS PHARMACEUTICALS INC·Filed 1995·Granted Aug 5, 1997·26 cites·6 claims
- 1265US5691461AOligonucleotides inhibiting candida germ tube formationISIS PHARMACEUTICALS INC·Filed 1994·Granted Nov 25, 1997·22 cites·7 claims
- 1365US5596090AAntisense oligonucleotides directed against human VCAM-1 RNAUS ARMY·Filed 1993·Granted Jan 21, 1997·25 cites·3 claims
- 1465US5580969AAntisense oligonucleotides directed against human ICAM-I RNAUS ARMY·Filed 1993·Granted Dec 3, 1996·25 cites·2 claims
- 1559US5994319ACombination therapy for androgenic alopecia with antisense oligonucleotides and minoxidilDYAD PHARMACEUTICAL CORP·Filed 1997·Granted Nov 30, 1999·20 cites·6 claims
- 1655US2005095606A1Partially double-stranded nucleic acids, methods of making, and use thereofFiled 2004·Application pending·0 cites
- 1752US2005170375A1Methods for enhancing gene expression analysisGENE LOGIC INC·Filed 2004·Application pending·0 cites
- 1850US2003129624A1Methods of preparing amplified nucleic acid moleculesGENE LOGIC INC·Filed 2002·Application pending·0 cites
- 1949US2005221310A1Methods for enhancing gene expression analysisGENE OGIC INC·Filed 2004·Application pending·0 cites
- 2048US2002127575A1Partially double-stranded nucleic acids, methods of making, and use thereofFiled 2001·Application pending·0 cites
- 2143US2008207545A1Methods and Compositions for Treating 5Alpha-Reductase Type 1 and Type 2 Dependent ConditionsHOKE GLENN D·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →